Key Market Indicators
Israeli Diagnostic Reagent Export is projected to drop to approximately $30 million by 2028, down from nearly $31 million in 2023. This decline represents an annual decrease of 0.4% in the compound annual growth rate (CAGR). Despite this downturn, Israeli supply has shown a steady increase of 3.3% annually since 2000. In 2023, Israel held the 31st position in global rankings, with Hungary slightly ahead, also at nearly $31 million. Germany, the Netherlands, and the United Kingdom occupied the second, third, and fourth spots, respectively. Conversely, Israeli Diagnostic Reagent Import is expected to climb to around $163 million by 2028, up from approximately $148 million in 2023. This growth indicates an annual increase of 1.6% in CAGR. Since 2000, Israeli demand for diagnostic reagents has risen by 2% each year.
